MINIMALLY INVASIVE SURGERY HUB

MIS device market analysis and updates

With advancements in minimally invasive surgery (MIS) techniques and devices, MIS adoption is expanding in many surgical specialties including orthopaedic surgery for hip and knee replacements and in cardiac surgery for coronary artery bypass surgery (CABG) and valvular surgery.

Clearstate offers market data, forecasts and trend predictions to give you the insight on how and where businesses can capture opportunities as surgeons adopt new techniques and technologies in MIS. Our MIS hub is regularly updated to share our findings on this fast expanding surgical technique.

Inquire now

What is minimally invasive surgery (MIS)?

Minimally invasive surgery (MIS) is done through smaller incisions compared with traditional open surgery, bringing about shorter recovery time and reduced risks and complications. There is growing demand for endoscopic or MIS devices and platforms and surgical technologies such as robotic-assisted surgical systems that can help surgeons perform more precise and less invasive procedures.

Explore the latest MIS market insights

From market news to analysis, our articles provide concise and up-to-date information about the developments shaping the future of MIS. Uncover the challenges and opportunities ahead to improve access to MIS procedures. Explore the latest in MIS market developments such as the availability of more portable, modular and economical MIS robotic systems which offer greater access to robotic procedures. Understand the impact of the shift to MIS procedures, and examine the challenges in cost, infrastructure and access of MIS.

Trends in minimally invasive cardiovascular surgery in Japan

A new wave of minimally invasive surgery (MIS) adoption in Japan is emerging due to improved technology and the availability of reimbursement and surgical devices.

Key domestic market players shaping the future of TAVR in China

Emergent covid-19 screening technologies coupled with declining testing demand are likely to erode the molecular-based covid-19 test market in Asia-Pacific (APAC) over the next five years.

TAVR bioprosthetic heart valve market to grow between 20-25% in east Asia

Transcatheter aortic valve replacements (TAVR) is set to be one of the fastest-growing procedural areas in cardiac surgery for Asia. Opportunities are growing particularly in east Asia as the number of TAVR candidates rises in an aging population, and with an expanding indication towards younger, lower-risk patients.

TAVR Japan: A third of procedures carried out in small and mid-sized hospitals

Transcatheter aortic valve replacements (TAVR) is set to be Japan’s fastest-growing procedural areas in cardiac surgery. Opportunities are growing particularly as the number of TAVR candidates rises in an aging population, and with an expanding indication towards younger, lower-risk patients.

Minimally Invasive Surgery: Trends in Cardiology

With better surgery outcomes and shorter patient recovery times, minimally invasive surgery (MIS) techniques have been increasingly adopted in cardiology procedures such as heart valve replacement surgeries.

Understand the MIS market

Discover more surgical device market insights and learn how our Surgical Gateway solution can help prepare your business for the growing MIS volume.

report by clearstate

The Future of TAVR in Asia

Understand the future of cardiac surgery in Asia, with our prescient insight into the cardiovascular surgery sector. Explore openings in the market as transcatheter aortic valve replacements (TAVR) will be one of the fastest-growing procedural areas in cardiac surgery for the region. The report examines Asia’s TAVR market landscape and the strategy implications that could enable improvements in TAVR access for the region.

Learn more

Clearstate newsletter

Sign up to our newsletter for insights into key market data, trends and developments across IVD and Surgical segments from our specialists and analysts.